ARCHIVES

NCI Ends Brash Foray Into the News Business—Emails Tell the Story of the NCI Cancer Bulletin

This article is from The Cancer Letter archive.

Vol. 39 No. 05 | February 1, 2013

Download PDF Visit The Full Archive

Related Articles

Velcade Plus Dexamethasone Provides 20% Response In First-Line Treatment

December 29, 2006

DCPC Board Defers Decision On Hepatitis Vaccine Study, Rejects PAP Sensitivity Concepts

June 1, 1984

NCI Seeks Applications For Small Business Research Awards

February 28, 1997

In Brief: Clinical Education Program to Be Phased Out; Ken Endicott Retires From Grupenhoff Firm

January 31, 1986

Cancer Act Impact; Mortality Decline; DeVita Tells ACCC

October 9, 1992

In Brief: David Harrington Replaces Zelen At ECOG; Kushnet To Receive Ewing Layman’s Award

December 1, 1989